advertisement
Hu Y 26
Showing records 1 to 25 | Display all abstracts from Hu Y108175 Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Liu P
Molecular therapy. Nucleic acids 2023; 32: 13-27
107935 The associations and mediators between visual disabilities and anxiety disorders in middle-aged and older adults: A population-based study
Zhang X
The American psychologist 2023; 78: 982-994
108553 Relationship between high dose intake of vitamin B12 and glaucoma: Evidence from NHANES 2005-2008 among United States adults
Liu Z; Hu Y
Frontiers in nutrition 2023; 10: 1130032
108175 Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Chen W
Molecular therapy. Nucleic acids 2023; 32: 13-27
107935 The associations and mediators between visual disabilities and anxiety disorders in middle-aged and older adults: A population-based study
Wang S; Du Z
The American psychologist 2023; 78: 982-994
108553 Relationship between high dose intake of vitamin B12 and glaucoma: Evidence from NHANES 2005-2008 among United States adults
Wang Y
Frontiers in nutrition 2023; 10: 1130032
108175 Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Jiang H
Molecular therapy. Nucleic acids 2023; 32: 13-27
108553 Relationship between high dose intake of vitamin B12 and glaucoma: Evidence from NHANES 2005-2008 among United States adults
Xu B
Frontiers in nutrition 2023; 10: 1130032
108175 Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Huang H
Molecular therapy. Nucleic acids 2023; 32: 13-27
107935 The associations and mediators between visual disabilities and anxiety disorders in middle-aged and older adults: A population-based study
Seth I
The American psychologist 2023; 78: 982-994
108553 Relationship between high dose intake of vitamin B12 and glaucoma: Evidence from NHANES 2005-2008 among United States adults
Zhao J
Frontiers in nutrition 2023; 10: 1130032
107935 The associations and mediators between visual disabilities and anxiety disorders in middle-aged and older adults: A population-based study
Wang Y
The American psychologist 2023; 78: 982-994
108175 Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Liu L
Molecular therapy. Nucleic acids 2023; 32: 13-27
107935 The associations and mediators between visual disabilities and anxiety disorders in middle-aged and older adults: A population-based study
Liang Y
The American psychologist 2023; 78: 982-994
108175 Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Fang F
Molecular therapy. Nucleic acids 2023; 32: 13-27
108553 Relationship between high dose intake of vitamin B12 and glaucoma: Evidence from NHANES 2005-2008 among United States adults
Yu Z
Frontiers in nutrition 2023; 10: 1130032
107935 The associations and mediators between visual disabilities and anxiety disorders in middle-aged and older adults: A population-based study
Wu G
The American psychologist 2023; 78: 982-994
108175 Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Li L; Feng X
Molecular therapy. Nucleic acids 2023; 32: 13-27
107935 The associations and mediators between visual disabilities and anxiety disorders in middle-aged and older adults: A population-based study
Huang Y; Liu S
The American psychologist 2023; 78: 982-994
108175 Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Liu D; Dalal R
Molecular therapy. Nucleic acids 2023; 32: 13-27
107935 The associations and mediators between visual disabilities and anxiety disorders in middle-aged and older adults: A population-based study
Shang X
The American psychologist 2023; 78: 982-994
108175 Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Sun Y; Jafar-Nejad P
Molecular therapy. Nucleic acids 2023; 32: 13-27
107935 The associations and mediators between visual disabilities and anxiety disorders in middle-aged and older adults: A population-based study
Hu Y
The American psychologist 2023; 78: 982-994
108175 Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Ling K
Molecular therapy. Nucleic acids 2023; 32: 13-27
107935 The associations and mediators between visual disabilities and anxiety disorders in middle-aged and older adults: A population-based study
Zhu Z; Yu H
The American psychologist 2023; 78: 982-994
